Metforal Xr

Metformin Hydrochloride, the active ingredient in Metforal Xr, is a biguanide presented as an oral tablet for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus.

GNH USA supplies Metforal Xr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metforal Xr, a biguanide antidiabetic, works within the glucose regulation pathway to lower blood sugar levels. - Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c. - Prediabetes: helps delay progression to overt diabetes when combined with lifestyle changes. - Metabolic syndrome: contributes to better fasting glucose and insulin sensitivity.

Metforal Xr may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Vitamin B12 deficiency: may develop with long‑term use.

Metforal Xr requires careful monitoring in several clinical situations. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic function: avoid in patients with acute liver disease. - Vitamin B12 status: consider periodic testing during prolonged therapy. - Heart failure: use with caution in decompensated states. - Elderly patients: start at lower dose and titrate slowly. Store at room temperature: keep in the original container, protect from moisture and heat.

Metforal Xr can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of lactic acidosis. - Cimetidine: may raise metformin plasma concentrations. - Alcohol: potentiates risk of metabolic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment. - Thiazide diuretics: may enhance hypoglycemic effect.